Alnylam Pharmaceuticals
ALNY
#587
Rank
$34.25 B
Marketcap
$265.56
Share price
0.22%
Change (1 day)
44.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company